Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
Genistein by Humanetics for Pulmonary Radiation Toxicity: Likelihood of Approval
Genistein is under clinical development by Humanetics and currently in Phase II for Pulmonary Radiation Toxicity. According to GlobalData, Phase...